Middletown, DE -- (SBWIRE) -- 09/05/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: TASER International, Inc.(NASDAQ:TASR), Raptor Pharmaceutical Corp.(NASDAQ:RPTP), Venaxis Inc(NASDAQ:APPY), New York Mortgage Trust, Inc.(NASDAQ:NYMT)
TASER International, Inc. (NASDAQ:TASR) was a volume gainer of 1.92 million shares and the average volume of the stock remained 1.03 million shares. The stock opened the session at $12.00 and finished at the end of the day at $12.37 and the stock escalated +3.34% .The market capitalizations of the stock remained 631.66 million. The half-yearly trend of the stock remained positive +57.58%. TASER International, Inc. engages in the development, manufacture, and sale of conducted electrical weapons (CEWs) for use in law enforcement, federal, military, corrections, private security, and personal defense markets worldwide.
For How Long TASR will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Raptor Pharmaceutical Corp.(NASDAQ:RPTP) exchanged 1.88 million shares and the average volume remained 664,292.00 shares. The stock closed the session at $14.40 with the gain of +4.20%. Tracking three months and 6 months trends, the stock was at of +84.14% and +184.02%, respectively. Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. It engages in the research, manufacture, and commercialization of medicines to treat nephropathic cystinosis, non-alcoholic steatohepatitis (NASH), Huntington's disease (HD), and aldehyde dehydrogenase deficiency (ALDH2).
Will RPTP Continue To Move Higher? Find Out Here
Venaxis Inc(NASDAQ:APPY) enhanced +6.85% and its closing price was $1.56. The volume of the stock was 1.86 million shares and the average volume remained 618,701.00 shares. Yesterday, the stock traded amid the day price range of $1.45 - $1.59. The market capitalization of the stock remained 33.47 million. The beta of the stock remained 1.14. Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. The company?s research and development activities primarily focus on a human acute appendicitis blood-based test. Its lead product candidate includes APPY1, a blood-based diagnostic test designed to aid in the evaluation of patients for acute appendicitis.
Why Should Investors Buy APPY After The Recent Gain? Just Go Here and Find Out
New York Mortgage Trust, Inc.(NASDAQ:NYMT) exchanged 1.84 million shares in the previous trading session, and its average trading remained 876,032.00 shares. It closed the trading at $6.10. The market capitalization of the stock remained 388.90 million. YTD trend of the stock was negative -0.81%. New York Mortgage Trust, Inc., a real estate investment trust (REIT), engages in acquiring, investing in, financing, and managing mortgage-related and financial assets in the United States.
What NYMT’s Charts Are Signaling for Traders? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)